Modified CD15/CD16-CLL1 inhibitory CAR-T cells for mitigating granulocytopenia toxicities in the treatment of acute myeloid leukemia

CLL1 Chimeric antigen EXTRA GENTLE SHAMPOO UNSCENTED receptor T-cell (CAR-T) therapy, as a promising immunotherapeutic approach, has demonstrated its potential to enhance the prognosis of patients diagnosed with acute myeloid leukemia (AML).However, due to the overexpression of CLL1 on neutrophils, CAR-T cells not only eliminated tumor cells but al

read more